The full paper is online, but the quick version is that alerts for AKI did not improve clinical outcomes for AKI patients.  Not a bit. What's worse, in at least one group of patients, the alerts increased the rate of renal consult and the rate of dialysis.  For me, this was a lesson in unintended consequences, and a reminder of why randomized trials are so important.

See the full story at The Lancet:

Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial - The Lancet.